A/s Novo, Director at ANAPTYSBIO, INC (ANAB), sold 5,000 shares at $49.87 ($249K) on 2026-10-01, disclosed to the SEC on 2026-10-02.
Scheduled sale ($249k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| RETA | SELL | 2017-06-07 | $2.5M | — | Filing → |
| APEN | SELL | 2017-05-11 | $590K | — | Filing → |
| ANAB | BUY | 2017-02-01 | $750K | — | Filing → |